Decibel Therapeutics Stock Working Capital
| DBTXDelisted Stock | USD 3.08 0.02 0.65% |
Decibel Therapeutics fundamentals help investors to digest information that contributes to Decibel Therapeutics' financial success or failures. It also enables traders to predict the movement of Decibel Stock. The fundamental analysis module provides a way to measure Decibel Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Decibel Therapeutics stock.
Decibel |
Decibel Therapeutics Company Working Capital Analysis
Decibel Therapeutics' Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Decibel Therapeutics Working Capital | 85.59 M |
Most of Decibel Therapeutics' fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Decibel Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
CompetitionAccording to the company's disclosures, Decibel Therapeutics has a Working Capital of 85.59 M. This is 79.89% lower than that of the Biotechnology sector and 84.11% lower than that of the Health Care industry. The working capital for all United States stocks is 94.21% higher than that of the company.
Decibel Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Decibel Therapeutics' direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Decibel Therapeutics could also be used in its relative valuation, which is a method of valuing Decibel Therapeutics by comparing valuation metrics of similar companies.Decibel Therapeutics is currently under evaluation in working capital category among its peers.
Decibel Fundamentals
| Return On Equity | -0.77 | |||
| Return On Asset | -0.33 | |||
| Current Valuation | 62.95 M | |||
| Shares Outstanding | 25.13 M | |||
| Shares Owned By Insiders | 13.35 % | |||
| Shares Owned By Institutions | 61.90 % | |||
| Number Of Shares Shorted | 78.33 K | |||
| Price To Book | 0.67 X | |||
| EBITDA | (62.49 M) | |||
| Net Income | (63.01 M) | |||
| Cash And Equivalents | 125.65 M | |||
| Cash Per Share | 5.03 X | |||
| Total Debt | 14.05 M | |||
| Debt To Equity | 0.14 % | |||
| Current Ratio | 6.18 X | |||
| Book Value Per Share | 2.12 X | |||
| Cash Flow From Operations | (56.9 M) | |||
| Short Ratio | 0.60 X | |||
| Earnings Per Share | (2.56) X | |||
| Target Price | 7.63 | |||
| Number Of Employees | 68 | |||
| Beta | -0.21 | |||
| Market Capitalization | 127.14 M | |||
| Total Asset | 123.37 M | |||
| Retained Earnings | (277.52 M) | |||
| Working Capital | 85.59 M | |||
| Z Score | 1.44 | |||
| Net Asset | 123.37 M |
About Decibel Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Decibel Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Decibel Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Decibel Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Consideration for investing in Decibel Stock
If you are still planning to invest in Decibel Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Decibel Therapeutics' history and understand the potential risks before investing.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |